1-7 of 7
Erin Reid, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Insurance Status on Outcomes in Patients with AIDS-Defining Cancers

Jun Yang Jiang, Erin Reid, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 32.
https://doi.org/10.1182/blood-2020-138489
Published: 2020
Journal Articles

Interim Results from the First-in-Human Clinical Trial of Adct-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

John Radford, MD FRCP, Brad S. Kahl, MD, Mehdi Hamadani, MD, Carmelo Carlo-Stella, MD, Paolo Caimi, MD, Kirit M. Ardeshna, MBBChir, Jay Feingold, MD PhD, Shui He, PhD, Erin Reid, MD, Melhem Solh, MD, Ki-Young Chung, MD, Leonard Heffner, MD, David Ungar, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 398.
https://doi.org/10.1182/blood-2018-99-116081
Published: 2018
Journal Articles

Encouraging Early Results from the First in-Human Clinical Trial of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory B-Cell Lineage Non-Hodgkin Lymphoma

Brad S Kahl, MD, Mehdi Hamadani, MD, Paolo Caimi, MD, Carmelo Carlo-Stella, MD, Erin Reid, MD, Jay Feingold, MD PhD, Kirit M Ardeshna, MD, John Radford, MD, Melhem M Solh, MD, Ki-Young Chung, MD, Leonard Heffner, MD, Shui He, PhD, Joseph Boni, PhD, Owen Anthony O'Connor, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 187.
https://doi.org/10.1182/blood.V130.Suppl_1.187.187
Published: 2017
Journal Articles

Elucidating Exposure-Response (Safety and Efficacy) of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Containing Antibody Drug Conjugate, for Recommended Phase 2 Dose Determination in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Owen Anthony O'Connor, MD, Brad S Kahl, MD, Mehdi Hamadani, MD, Paolo Caimi, MD, Erin Reid, MD, Jay Feingold, MD PhD, Karin Havenith, PhD, Shui He, PhD, Diane R Mould, PhD, Immanuel Freedman, PhD, Joseph Boni, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2543.
https://doi.org/10.1182/blood.V130.Suppl_1.2543.2543
Published: 2017
Journal Articles

A Dose-Escalation Study of Venetoclax (ABT-199/GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Sven de Vos, MD PhD, Lode Swinnen, MD, Mark Kozloff, MD, Ding Wang, MD PhD, Erin Reid, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Jaclyn Cordero, Diane D'Amico, Susan Diehl, Martin Dunbar, DrPH, Ming Zhu, PhD, Shekman Wong, PhD, Sari Heitner Enschede, MD, David Chien, MD, Rod A. Humerickhouse, MD PhD, Christopher Flowers, MD
Journal: Blood
Blood (2015) 126 (23): 255.
https://doi.org/10.1182/blood.V126.23.255.255
Published: 2015
Journal Articles

Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial

Alexey V Danilov, MD PhD, Hongli Li, PhD, Oliver W. Press, Ilan Shapira, MD, Lode J. Swinnen, MBChB, Ariela Noy, MD, Erin Reid, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 1498.
https://doi.org/10.1182/blood.V126.23.1498.1498
Published: 2015
Journal Articles

The BCL-2 Inhibitor ABT-199 (GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Sven de Vos, MD PhD, Christopher R. Flowers, MD, Ding Wang, MD PhD, Lode J. Swinnen, Nathan Fowler, MD, Erin Reid, MD, Maryella Gifford, BS, Diane D'Amico, Martin Dunbar, DRPH, Ming Zhu, PhD, Jianning Yang, PhD, Sari H. Enschede, MD, Justin L. Ricker, MD PhD, David Chien, MD, Rod A. Humerickhouse, MD PhD, Mark Kozloff, MD
Journal: Blood
Blood (2014) 124 (21): 1722.
https://doi.org/10.1182/blood.V124.21.1722.1722
Published: 2014